title: With statin co-administration, drugs designed to increase HDL have no impact on cardiovascular outcomes.
authors.affiliation: Cardiovascular Research Group, University of Manchester, Manchester, UK.
authors.forename: Paul N
authors.initials: PN
authors.lastname: Durrington
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D058607:Fibric Acids / Q000627:therapeutic use*; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D009525:Niacin / Q000627:therapeutic use*
chemical_list: D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D058607:Fibric Acids; D008075:Lipoproteins, HDL; D009525:Niacin